Definitive Contract 75N93019C00040

Award Date 9/16/19
Potential Completion Date 9/15/25
Potential Value $10M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Menands, NY 12204, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
8
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed

This is a $10,279,321.93 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Health Research, Inc. (HRI), a non-profit organization. The contract is for "LYME DISEASE: B CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION" and has a completion date of September 15, 2025. The contract is a cost-no-fee arrangement and was not set aside for any specific business type. HRI is an established partner to the New York State Department of Health, managing a diverse portfolio of federal contracts and grants related to public health initiatives, disease surveillance, and medical research. This contract further demonstrates HRI's expertise in supporting critical public health services and medical research.

Generated 1/23/25, 9:37 AM